SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-325531
Filing Date
2013-08-08
Accepted
2013-08-08 07:46:18
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d542488d10q.htm 10-Q 548686
2 EX-31.1 d542488dex311.htm EX-31.1 7497
3 EX-31.2 d542488dex312.htm EX-31.2 7592
4 EX-32.1 d542488dex321.htm EX-32.1 3719
5 EX-32.2 d542488dex322.htm EX-32.2 3815
  Complete submission text file 0001193125-13-325531.txt   5101716

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT infi-20130630.xml EX-101.INS 427494
7 XBRL TAXONOMY EXTENSION SCHEMA infi-20130630.xsd EX-101.SCH 45380
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE infi-20130630_cal.xml EX-101.CAL 55573
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE infi-20130630_def.xml EX-101.DEF 216883
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20130630_lab.xml EX-101.LAB 324792
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20130630_pre.xml EX-101.PRE 251666
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31141 | Film No.: 131019922
SIC: 2834 Pharmaceutical Preparations